Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · Real-Time Price · USD
0.630
+0.010 (1.61%)
Dec 20, 2024, 4:00 PM EST - Market closed

Cyclo Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-24.8-20.06-15.45-14.29-8.94-7.53
Upgrade
Depreciation & Amortization
0.010.020.020.020.010.02
Upgrade
Loss (Gain) From Sale of Assets
0.01-----
Upgrade
Stock-Based Compensation
1.070.740.510.470.270.44
Upgrade
Provision & Write-off of Bad Debts
--0.010.020-
Upgrade
Other Operating Activities
2.230.05-0.16---0
Upgrade
Change in Accounts Receivable
0.12-0.070.43-0.440.07-0.06
Upgrade
Change in Inventory
-0.08-0.05-0.030.0100.16
Upgrade
Change in Accounts Payable
-0.63.25-0.20.410.141.12
Upgrade
Change in Other Net Operating Assets
-0.48-0.06-0.25-1.2-0.1-0.73
Upgrade
Operating Cash Flow
-22.52-16.19-15.11-15.01-8.54-6.59
Upgrade
Capital Expenditures
-0-0-0.02-0.02-0.05-0
Upgrade
Investing Cash Flow
-0-00.040.01-0.010.04
Upgrade
Long-Term Debt Issued
----0.16-
Upgrade
Total Debt Issued
10---0.16-
Upgrade
Long-Term Debt Repaid
---0.01-0.01--
Upgrade
Total Debt Repaid
---0.01-0.01--
Upgrade
Net Debt Issued (Repaid)
10--0.01-0.010.16-
Upgrade
Issuance of Common Stock
2.912.13-18.7617.477.57
Upgrade
Other Financing Activities
8.7511.760.01-0.98-0.45
Upgrade
Financing Cash Flow
21.6523.890.0118.7618.627.12
Upgrade
Net Cash Flow
-0.877.7-15.073.7710.060.57
Upgrade
Free Cash Flow
-22.52-16.19-15.13-15.03-8.59-6.59
Upgrade
Free Cash Flow Margin
-2586.35%-1503.84%-1099.71%-947.67%-951.24%-654.37%
Upgrade
Free Cash Flow Per Share
-0.83-0.99-1.79-2.36-5.37-6.09
Upgrade
Cash Interest Paid
00.01-00-
Upgrade
Levered Free Cash Flow
-13.05-8.26-9.23-9.95-4.98-3.68
Upgrade
Unlevered Free Cash Flow
-13.05-8.26-9.23-9.95-4.98-3.68
Upgrade
Change in Net Working Capital
-1.3-3.52-0.011.48-0.39-0.58
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.